MIT - Cellbiocan shows its progress in the fight against cancer
The biomedical company Cellbiocán has been distinguished by the Massachusetts Institute of Technology (MIT) and, endorsed by the Foundation for Health Innovation and Prospective in Spain (Fipse), will participate in the third edition of the Fipse International Mentoring Program that will begin next July in Boston (United States).